The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the onset of MS symptoms. Women with multiple sclerosis (MS) show increased risk ...

Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM) , a diversified, vertically integrated global healthcare ...

Multiple sclerosis, often shortened to 'MS', is a long-lasting chronic disease of the central nervous system. There is ...

Cosmos Health (COSM) announced the filing of a patent application for treatment for multiple sclerosis, a disabling autoimmune disorder ...

Scott, an internationally recognized neurologist and leader in multiple sclerosis (MS) research and clinical care, has been awarded the 2024 MS Research Award by MS Australia.

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

Follow-up treatments and regular monitoring are essential for ongoing symptom management. Botox is a valuable tool in the management of multiple sclerosis (MS), addressing key symptoms such as ...